Table 3.
Case author | Age, sex | IB yr. | BM treatment | OS Mo |
---|---|---|---|---|
Chondrosarcoma | ||||
Flannery et al., 2010 [15] | 14 M, 56 M | 0.5–1.3 | GKSRS | 18–21 |
Francés-Muñoz et al., 2012 [39] | 53 F | 10 | Chemo for lung | NR |
Kawaguchi et al., 2012 [43] | 54 M | 0.7 | Chemo | 52 |
Jallu et al., 1992 [41] | 54 F | 0.7 | SR | NR |
Konishi et al., 1994 [44] | 72 F | 2 | SR | 2 |
Reyaz and Ashraf, 2006 [45] | 34 F | 7 | SR | NR |
Talerman, 1967 [46] | 26 F | — | — | — |
Templeton et al., 1985 [47] | 15 M | 34 | D | NR |
Waga et al., 1972 [48] | 32 M | 12 | SR | NR |
Tsutsumi et al., 2010 [40] | 60 M | 4.4 | Chemo, GKSRS | 10+ |
Fox et al., 1968 [49] | 51 F | — | D | 11 |
| ||||
Chordoma | ||||
Kamel et al., 2005 [53] | 12 M | 32 | SR | 32 (alive) |
Anderson and Meyers, 1968 [54] | 69 M | 24 | SR (gross total) | 36 (alive) |
Al-Adra et al., 2011 [52] | 29 M | 16 | SR, WBRT | ? |
Morris and Rabinovitch, 1947 [56] | 41 M | 2.5 | WBRT | 2.5 |
Fichardt and De Villiers, 1974 [55] | 59 M | 36 | SR | 42 |
Higinbotham et al. 1967 [50] | 58 F | ? | None (autopsy finding) | 72 |
Mesgarzadeh et al., 2008 [57] | 27 F | 18 | None | 24 |
Chemo: chemotherapy; D: death prior to treatment; F: female; GKSRS: Gamma knife stereotactic radiosurgery; IB: interval between diagnosis of brain metastasis from chondrosarcoma in years (yr); M: male; NR: not reported; OS: overall survival in months; Radio: radiotherapy; SR: surgical resection; WBRT: whole brain radiotherapy; adiagnosed postmortem; bbrain metastasis diagnosed first; +: survival reported for at least the stated amount.